Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma
Clinical trial NCT00238433 · COMPLETED
Trial details
- NCT number
- NCT00238433
- Sponsor
- OHSU Knight Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-01
- Primary completion
- 2015-08-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.